Original Article
Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry
Seguridad y efectividad de los FAME biológicos durante el embarazo en pacientes con enfermedades reumáticas: datos del mundo real procedentes del registro BIOBADASER
Cristina Membrive-Jiméneza,
, Carlos Sánchez-Piedrab, Olga Martínez-Gonzálezc, Javier García-Gonzálezd, Lorena Expósito-Péreze, Cristina Bohórquez-Herasf, Cristina Campos-Fernándezg, Fernando Sanchez-Alonsob, Rafael Cáliz-Cáliza, Isabel Castrejón-Fernándezh
Corresponding author
a Rheumatology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain
b Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain
c Rheumatology Department, Hospital Universitario de Salamanca, Salamanca, Spain
d Rheumatology Department, Hospital Universitario Doce de Octubre, Huesca, Spain
e Rheumatology Department, Hospital Universitario de Canarias, La Laguna, Spain
f Rheumatology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
g Rheumatology Department, Hospital General Universitario de Valencia, Valencia, Spain
h Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Read
1716
Timeswas read the article
656
Total PDF
1060
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 2 | 16 | 18 |
| 2025 5 | 111 | 73 | 184 |
| 2025 4 | 115 | 57 | 172 |
| 2025 3 | 88 | 41 | 129 |
| 2025 2 | 109 | 35 | 144 |
| 2025 1 | 88 | 66 | 154 |
| 2024 12 | 86 | 32 | 118 |
| 2024 11 | 73 | 58 | 131 |
| 2024 10 | 45 | 45 | 90 |
| 2024 9 | 53 | 31 | 84 |
| 2024 8 | 85 | 72 | 157 |
| 2024 7 | 88 | 37 | 125 |
| 2024 6 | 63 | 48 | 111 |
| 2024 5 | 54 | 45 | 99 |
Show all
